Patent details

EP2104510 Title: USE OF AT LEAST ONE BOTULISM NEUROTOXIN FOR TREATING THE PAIN INDUCED BY THERAPEUTIC TREATMENTS FOR THE AIDS VIRUS

Basic Information

Publication number:
EP2104510
PCT Application Number:
PCT/FR/2007/002091
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078723806
PCT Publication Number:
WO/2008/090287
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
USE OF AT LEAST ONE BOTULISM NEUROTOXIN FOR TREATING THE PAIN INDUCED BY THERAPEUTIC TREATMENTS FOR THE AIDS VIRUS
French Title of Invention:
UTILISATION D'AU MOINS UNE NEUROTOXINE BOTULIQUE POUR TRAITER LA DOULEUR INDUITE PAR LES TRAITEMENTS THERAPEUTIQUES DU VIRUS DU SIDA
German Title of Invention:
VERWENDUNG VON MINDESTENS EINEM BOTULINUM-NEUROTOXIN ZUR BEHANDLUNG VON SCHMERZEN INFOLGE THERAPEUTISCHER BEHANDLUNGEN FÜR DAS AIDS-VIRUS
SPC Number:

Dates

Filing date:
17/12/2007
Grant date:
21/09/2011
EP Publication Date:
21/09/2011
PCT Publication Date:
31/07/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/09/2009
EP B1 Publication Date:
21/09/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/12/2011
Expiration date:
17/12/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/12/2007
 
 

Name:
IPSEN PHARMA S.A.S.
Address:
65, Quai Georges Gorse, 92100 Boulogne-Billancourt, France (FR)

Inventor

1

Name:
Chabrier De Lassauniere Pierre-Etienne
Address:
France (FR)

2

Name:
Favre Christine
Address:
France (FR)

3

Name:
Auguet Michel
Address:
France (FR)

Priority

Priority Number:
0611244
Priority Date:
22/12/2006
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 38/48;
Filing date Document type Number of pages